MarketPeel
Insider Trading Intelligence
EVP R&D, Chief Medical Officer
Wed, Feb 18, 2026
Feb 18
exercised or converted securities in ALKS
8,897 shares @ $0.00
Decreased holdings by -100.00%
Net across this filing: +7.10% (+5,393 shares)
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.62%
3M
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback